Filing Manager
CVI Investments, Inc.
Reporting Manager
CVI Investments, Inc.
Symbol
BCTX
Shares outstanding
5,688,372 shares
Disclosed Ownership
489,200 shares
Ownership
8.6%
Form type
SCHEDULE 13G
Filing time
01 May 2025, 10:01:03 UTC
Date of event
24 Apr 2025
Next filing
21 Jul 2025

Quoteable Key Fact

"CVI Investments, Inc. disclosed 8.6% ownership in BriaCell Therapeutics Corp. Common Shares, no par value (BCTX) on 24 Apr 2025."

Quick Takeaways

  • CVI Investments, Inc. filed SCHEDULE 13G for BriaCell Therapeutics Corp. Common Shares, no par value (BCTX).
  • Disclosed ownership: 8.6%.
  • Date of event: 24 Apr 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 01 May 2025, 10:01.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
CVI Investments, Inc. 8.6% 489,200 0 489,200 /s/ Brian Sopinsky Brian Sopinsky, Secretary of Heights Capital Management, Inc.
Heights Capital Management, Inc. 8.6% 489,200 0 489,200 /s/ Brian Sopinsky Brian Sopinsky, Secretary